Invesco Ltd. Syros Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.69 - $1.21 $13,185 - $23,121	-19,109 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.02 - $3.8 $94 - $353	93 Added 0.49%	19,109 $23,000
Q4 2021 Feb 14, 2022	SELL	$3.26 - $4.66 $9,216 - $13,173	-2,827 Reduced 12.94%	19,016 $62,000
Q3 2021 Nov 15, 2021	BUY	$4.08 - $5.66 $14,806 - $20,540	3,629 Added 19.92%	21,843 $97,000
Q2 2021 Aug 17, 2021	BUY	$5.01 - $7.48 $35,250 - $52,629	7,036 Added 62.95%	18,214 $99,000
Q1 2021 May 17, 2021	BUY	$7.19 - $14.95 $80,369 - $167,111	11,178 New	11,178 $84,000
Q2 2020 Aug 14, 2020	SELL	$5.21 - $11.03 $468,967 - $992,843	-90,013 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$4.46 - $9.2 $401,457 - $828,119	90,013 New	90,013 $534,000
Q4 2019 Feb 14, 2020	SELL	$4.52 - $10.1 $349,007 - $779,861	-77,214 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$7.14 - $11.65 $551,307 - $899,543	77,214 New	77,214 $801,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.